RedHill Biopharma RDHL
NASDAQ RDHL
$0.46 -0.05 (-10.31%)
As of: Oct 21, 2026 · 3:45 PM EDT

RedHill Biopharma (RDHL) Notes Payables (2022)

Updated

RedHill Biopharma (RDHL) posted Notes Payables of $115.22 million for the quarter ended Dec 31, 2022.

Analysis

RedHill Biopharma (RDHL) Notes Payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 RedHill Biopharma 1.44 Mn -15.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 115.22 Mn
Jun 30, 2022 85.51 Mn
API Access

RedHill Biopharma Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RDHL&period=max&api_key=YOUR_API_KEY